1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Primary Aldosteronism Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Blood Test 1.2.3 Imaging Test 1.3 Market by Application 1.3.1 Global Primary Aldosteronism Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Hospitals 1.3.3 Specialty Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Primary Aldosteronism Market Perspective (2018-2029) 2.2 Primary Aldosteronism Growth Trends by Region 2.2.1 Global Primary Aldosteronism Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Primary Aldosteronism Historic Market Size by Region (2018-2023) 2.2.3 Primary Aldosteronism Forecasted Market Size by Region (2024-2029) 2.3 Primary Aldosteronism Market Dynamics 2.3.1 Primary Aldosteronism Industry Trends 2.3.2 Primary Aldosteronism Market Drivers 2.3.3 Primary Aldosteronism Market Challenges 2.3.4 Primary Aldosteronism Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Primary Aldosteronism Players by Revenue 3.1.1 Global Top Primary Aldosteronism Players by Revenue (2018-2023) 3.1.2 Global Primary Aldosteronism Revenue Market Share by Players (2018-2023) 3.2 Global Primary Aldosteronism Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Primary Aldosteronism Revenue 3.4 Global Primary Aldosteronism Market Concentration Ratio 3.4.1 Global Primary Aldosteronism Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Primary Aldosteronism Revenue in 2022 3.5 Primary Aldosteronism Key Players Head office and Area Served 3.6 Key Players Primary Aldosteronism Product Solution and Service 3.7 Date of Enter into Primary Aldosteronism Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Primary Aldosteronism Breakdown Data by Type 4.1 Global Primary Aldosteronism Historic Market Size by Type (2018-2023) 4.2 Global Primary Aldosteronism Forecasted Market Size by Type (2024-2029) 5 Primary Aldosteronism Breakdown Data by Application 5.1 Global Primary Aldosteronism Historic Market Size by Application (2018-2023) 5.2 Global Primary Aldosteronism Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Primary Aldosteronism Market Size (2018-2029) 6.2 North America Primary Aldosteronism Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Primary Aldosteronism Market Size by Country (2018-2023) 6.4 North America Primary Aldosteronism Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Primary Aldosteronism Market Size (2018-2029) 7.2 Europe Primary Aldosteronism Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Primary Aldosteronism Market Size by Country (2018-2023) 7.4 Europe Primary Aldosteronism Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Primary Aldosteronism Market Size (2018-2029) 8.2 Asia-Pacific Primary Aldosteronism Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Primary Aldosteronism Market Size by Region (2018-2023) 8.4 Asia-Pacific Primary Aldosteronism Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Primary Aldosteronism Market Size (2018-2029) 9.2 Latin America Primary Aldosteronism Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Primary Aldosteronism Market Size by Country (2018-2023) 9.4 Latin America Primary Aldosteronism Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Primary Aldosteronism Market Size (2018-2029) 10.2 Middle East & Africa Primary Aldosteronism Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Primary Aldosteronism Market Size by Country (2018-2023) 10.4 Middle East & Africa Primary Aldosteronism Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Detail 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Primary Aldosteronism Introduction 11.1.4 Pfizer Revenue in Primary Aldosteronism Business (2018-2023) 11.1.5 Pfizer Recent Development 11.2 Sun Pharmaceutical Industries 11.2.1 Sun Pharmaceutical Industries Company Detail 11.2.2 Sun Pharmaceutical Industries Business Overview 11.2.3 Sun Pharmaceutical Industries Primary Aldosteronism Introduction 11.2.4 Sun Pharmaceutical Industries Revenue in Primary Aldosteronism Business (2018-2023) 11.2.5 Sun Pharmaceutical Industries Recent Development 11.3 Bristol Laboratories 11.3.1 Bristol Laboratories Company Detail 11.3.2 Bristol Laboratories Business Overview 11.3.3 Bristol Laboratories Primary Aldosteronism Introduction 11.3.4 Bristol Laboratories Revenue in Primary Aldosteronism Business (2018-2023) 11.3.5 Bristol Laboratories Recent Development 11.4 CMP Pharma 11.4.1 CMP Pharma Company Detail 11.4.2 CMP Pharma Business Overview 11.4.3 CMP Pharma Primary Aldosteronism Introduction 11.4.4 CMP Pharma Revenue in Primary Aldosteronism Business (2018-2023) 11.4.5 CMP Pharma Recent Development 11.5 Koninklijke Philips 11.5.1 Koninklijke Philips Company Detail 11.5.2 Koninklijke Philips Business Overview 11.5.3 Koninklijke Philips Primary Aldosteronism Introduction 11.5.4 Koninklijke Philips Revenue in Primary Aldosteronism Business (2018-2023) 11.5.5 Koninklijke Philips Recent Development 11.6 GE Healthcare 11.6.1 GE Healthcare Company Detail 11.6.2 GE Healthcare Business Overview 11.6.3 GE Healthcare Primary Aldosteronism Introduction 11.6.4 GE Healthcare Revenue in Primary Aldosteronism Business (2018-2023) 11.6.5 GE Healthcare Recent Development 11.7 Siemens 11.7.1 Siemens Company Detail 11.7.2 Siemens Business Overview 11.7.3 Siemens Primary Aldosteronism Introduction 11.7.4 Siemens Revenue in Primary Aldosteronism Business (2018-2023) 11.7.5 Siemens Recent Development 11.8 Shimadzu Corporation 11.8.1 Shimadzu Corporation Company Detail 11.8.2 Shimadzu Corporation Business Overview 11.8.3 Shimadzu Corporation Primary Aldosteronism Introduction 11.8.4 Shimadzu Corporation Revenue in Primary Aldosteronism Business (2018-2023) 11.8.5 Shimadzu Corporation Recent Development 11.9 Canon 11.9.1 Canon Company Detail 11.9.2 Canon Business Overview 11.9.3 Canon Primary Aldosteronism Introduction 11.9.4 Canon Revenue in Primary Aldosteronism Business (2018-2023) 11.9.5 Canon Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Primary Aldosteronism Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Blood Test Table 3. Key Players of Imaging Test Table 4. Global Primary Aldosteronism Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 5. Global Primary Aldosteronism Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 6. Global Primary Aldosteronism Market Size by Region (2018-2023) & (US$ Million) Table 7. Global Primary Aldosteronism Market Share by Region (2018-2023) Table 8. Global Primary Aldosteronism Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 9. Global Primary Aldosteronism Market Share by Region (2024-2029) Table 10. Primary Aldosteronism Market Trends Table 11. Primary Aldosteronism Market Drivers Table 12. Primary Aldosteronism Market Challenges Table 13. Primary Aldosteronism Market Restraints Table 14. Global Primary Aldosteronism Revenue by Players (2018-2023) & (US$ Million) Table 15. Global Primary Aldosteronism Market Share by Players (2018-2023) Table 16. Global Top Primary Aldosteronism Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Aldosteronism as of 2022) Table 17. Ranking of Global Top Primary Aldosteronism Companies by Revenue (US$ Million) in 2022 Table 18. Global 5 Largest Players Market Share by Primary Aldosteronism Revenue (CR5 and HHI) & (2018-2023) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Primary Aldosteronism Product Solution and Service Table 21. Date of Enter into Primary Aldosteronism Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Primary Aldosteronism Market Size by Type (2018-2023) & (US$ Million) Table 24. Global Primary Aldosteronism Revenue Market Share by Type (2018-2023) Table 25. Global Primary Aldosteronism Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 26. Global Primary Aldosteronism Revenue Market Share by Type (2024-2029) Table 27. Global Primary Aldosteronism Market Size by Application (2018-2023) & (US$ Million) Table 28. Global Primary Aldosteronism Revenue Market Share by Application (2018-2023) Table 29. Global Primary Aldosteronism Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 30. Global Primary Aldosteronism Revenue Market Share by Application (2024-2029) Table 31. North America Primary Aldosteronism Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 32. North America Primary Aldosteronism Market Size by Country (2018-2023) & (US$ Million) Table 33. North America Primary Aldosteronism Market Size by Country (2024-2029) & (US$ Million) Table 34. Europe Primary Aldosteronism Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 35. Europe Primary Aldosteronism Market Size by Country (2018-2023) & (US$ Million) Table 36. Europe Primary Aldosteronism Market Size by Country (2024-2029) & (US$ Million) Table 37. Asia-Pacific Primary Aldosteronism Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 38. Asia-Pacific Primary Aldosteronism Market Size by Region (2018-2023) & (US$ Million) Table 39. Asia-Pacific Primary Aldosteronism Market Size by Region (2024-2029) & (US$ Million) Table 40. Latin America Primary Aldosteronism Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 41. Latin America Primary Aldosteronism Market Size by Country (2018-2023) & (US$ Million) Table 42. Latin America Primary Aldosteronism Market Size by Country (2024-2029) & (US$ Million) Table 43. Middle East & Africa Primary Aldosteronism Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 44. Middle East & Africa Primary Aldosteronism Market Size by Country (2018-2023) & (US$ Million) Table 45. Middle East & Africa Primary Aldosteronism Market Size by Country (2024-2029) & (US$ Million) Table 46. Pfizer Company Detail Table 47. Pfizer Business Overview Table 48. Pfizer Primary Aldosteronism Product Table 49. Pfizer Revenue in Primary Aldosteronism Business (2018-2023) & (US$ Million) Table 50. Pfizer Recent Development Table 51. Sun Pharmaceutical Industries Company Detail Table 52. Sun Pharmaceutical Industries Business Overview Table 53. Sun Pharmaceutical Industries Primary Aldosteronism Product Table 54. Sun Pharmaceutical Industries Revenue in Primary Aldosteronism Business (2018-2023) & (US$ Million) Table 55. Sun Pharmaceutical Industries Recent Development Table 56. Bristol Laboratories Company Detail Table 57. Bristol Laboratories Business Overview Table 58. Bristol Laboratories Primary Aldosteronism Product Table 59. Bristol Laboratories Revenue in Primary Aldosteronism Business (2018-2023) & (US$ Million) Table 60. Bristol Laboratories Recent Development Table 61. CMP Pharma Company Detail Table 62. CMP Pharma Business Overview Table 63. CMP Pharma Primary Aldosteronism Product Table 64. CMP Pharma Revenue in Primary Aldosteronism Business (2018-2023) & (US$ Million) Table 65. CMP Pharma Recent Development Table 66. Koninklijke Philips Company Detail Table 67. Koninklijke Philips Business Overview Table 68. Koninklijke Philips Primary Aldosteronism Product Table 69. Koninklijke Philips Revenue in Primary Aldosteronism Business (2018-2023) & (US$ Million) Table 70. Koninklijke Philips Recent Development Table 71. GE Healthcare Company Detail Table 72. GE Healthcare Business Overview Table 73. GE Healthcare Primary Aldosteronism Product Table 74. GE Healthcare Revenue in Primary Aldosteronism Business (2018-2023) & (US$ Million) Table 75. GE Healthcare Recent Development Table 76. Siemens Company Detail Table 77. Siemens Business Overview Table 78. Siemens Primary Aldosteronism Product Table 79. Siemens Revenue in Primary Aldosteronism Business (2018-2023) & (US$ Million) Table 80. Siemens Recent Development Table 81. Shimadzu Corporation Company Detail Table 82. Shimadzu Corporation Business Overview Table 83. Shimadzu Corporation Primary Aldosteronism Product Table 84. Shimadzu Corporation Revenue in Primary Aldosteronism Business (2018-2023) & (US$ Million) Table 85. Shimadzu Corporation Recent Development Table 86. Canon Company Detail Table 87. Canon Business Overview Table 88. Canon Primary Aldosteronism Product Table 89. Canon Revenue in Primary Aldosteronism Business (2018-2023) & (US$ Million) Table 90. Canon Recent Development Table 91. Research Programs/Design for This Report Table 92. Key Data Information from Secondary Sources Table 93. Key Data Information from Primary Sources List of Figures Figure 1. Global Primary Aldosteronism Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Primary Aldosteronism Market Share by Type: 2022 VS 2029 Figure 3. Blood Test Features Figure 4. Imaging Test Features Figure 5. Global Primary Aldosteronism Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 6. Global Primary Aldosteronism Market Share by Application: 2022 VS 2029 Figure 7. Hospitals Case Studies Figure 8. Specialty Clinic Case Studies Figure 9. Others Case Studies Figure 10. Primary Aldosteronism Report Years Considered Figure 11. Global Primary Aldosteronism Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 12. Global Primary Aldosteronism Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 13. Global Primary Aldosteronism Market Share by Region: 2022 VS 2029 Figure 14. Global Primary Aldosteronism Market Share by Players in 2022 Figure 15. Global Top Primary Aldosteronism Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Aldosteronism as of 2022) Figure 16. The Top 10 and 5 Players Market Share by Primary Aldosteronism Revenue in 2022 Figure 17. North America Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 18. North America Primary Aldosteronism Market Share by Country (2018-2029) Figure 19. United States Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 20. Canada Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 21. Europe Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Europe Primary Aldosteronism Market Share by Country (2018-2029) Figure 23. Germany Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. France Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 25. U.K. Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. Italy Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. Russia Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Nordic Countries Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Asia-Pacific Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Asia-Pacific Primary Aldosteronism Market Share by Region (2018-2029) Figure 31. China Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Japan Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. South Korea Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Southeast Asia Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. India Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Australia Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. Latin America Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Latin America Primary Aldosteronism Market Share by Country (2018-2029) Figure 39. Mexico Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Brazil Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. Middle East & Africa Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Middle East & Africa Primary Aldosteronism Market Share by Country (2018-2029) Figure 43. Turkey Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Saudi Arabia Primary Aldosteronism Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Pfizer Revenue Growth Rate in Primary Aldosteronism Business (2018-2023) Figure 46. Sun Pharmaceutical Industries Revenue Growth Rate in Primary Aldosteronism Business (2018-2023) Figure 47. Bristol Laboratories Revenue Growth Rate in Primary Aldosteronism Business (2018-2023) Figure 48. CMP Pharma Revenue Growth Rate in Primary Aldosteronism Business (2018-2023) Figure 49. Koninklijke Philips Revenue Growth Rate in Primary Aldosteronism Business (2018-2023) Figure 50. GE Healthcare Revenue Growth Rate in Primary Aldosteronism Business (2018-2023) Figure 51. Siemens Revenue Growth Rate in Primary Aldosteronism Business (2018-2023) Figure 52. Shimadzu Corporation Revenue Growth Rate in Primary Aldosteronism Business (2018-2023) Figure 53. Canon Revenue Growth Rate in Primary Aldosteronism Business (2018-2023) Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

Pfizer Sun Pharmaceutical Industries Bristol Laboratories CMP Pharma Koninklijke Philips GE Healthcare Siemens Shimadzu Corporation Canon